PANDORE-PANC-IPC 2021-082

About this trial

Last updated 2 years ago

Study ID

Status

Not yet recruiting

Type

Interventional

Phase

N/A

Placebo

Accepting

18+ Years

All

Not accepting

Healthy Volunteers

Trial Timing

Started 2 years ago

The study consists of a 25 ml blood sample collection: - Before the start of treatment - Approximately 2 months after the start of induction chemotherapy - At the end of induction chemotherapy - Prior to local treatment (radiotherapy, surgery) - At the time of tumor progression Collection of tumor material: - During the initial diagnostic biopsy - On the operating room in case of surgery - At tumor biopsy in case of recurrence or progression (optional) As well as the completion of a questionnaire at inclusion.

Inclusion Criteria

- Non-metastatic pancreatic adenocarcinoma that is not immediately resectable (borderline and locally advanced tumors according to the NCCN 2020 classification)

- No previous treatment with surgery or chemotherapy

- Age > 18 years

- General condition WHO 0-2 (patient whose general condition can allow medical treatment or surgery)

- Therapeutic management at the Paoli-Calmettes Institute

- Signature of the informed consent specific to the PANDORE-PANC study

- Patient affiliated to a social security system or benefiting from such a system

Exclusion Criteria

- Metastatic disease

- Pancreatic tumor of a histological type other than adenocarcinoma

- Other tumor under treatment or for which treatments have been completed for < 1 year

- Pregnant or breastfeeding women

- Person in an emergency situation

- Person of legal age under legal protection (guardianship, curatorship or safeguard of justice) or unable to give consent.

PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT